Thermo Fisher Scientific Extends Collaboration to Advance Biopharmaceutical Discovery and Development October 29, 2020October 29, 2020 by / Share This.....LinkedinTwitterFacebookGoogleEmailThermo Fisher and Symphogen continue work to support the development of innovative cancer treatments through optimization of protein characterization and quality monitoring mass spectrometry workflows Related News: Thermo Fisher Scientific Extends the Expiration of…PerkinElmer Streamlines Flow Cytometry Management…Bruker Leads $46 Million New Financing Round for…GE Healthcare Announces Collaboration to Advance…Thermo Fisher Scientific Introduces Groundbreaking…Thermo Fisher Scientific to Help Advance Myeloid…
